United Therapeutics (UTHR) announced that the FDA has cleared its investigational new drug application to initiate a clinical study of the ...
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., January 21, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The National Comprehensive Cancer Network® (NCCN®) is joining people and organizations across the globe to commemorate World ...
As Elon Musk moves to shutter the U.S. Agency for International Development, the agency’s support for the discovery of novel ...
SEC Filings provided by EDGAR Online, Inc.
Roche Holding AG Akt-0.78% CHF230.86B ...